CF CF Industries

Q3 2025 10-Q

Filed: Nov 6, 2025Period ending Sep 30, 2025

Health Care

Agricultural ChemicalsSEC EDGAR

CF Industries (CF) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• No quarterly revenue or YoY change data disclosed in provided text
• No profitability or margin figures reported in provided text

+3 more insights

Risk Factors

• New project execution risk triggered by construction delays or cost overruns at Blue Point low-carbon ammonia facility
• Increased capital expenditure risk as project funding needs at Blue Point may exceed current estimates

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.7B

Net Income

$353M

Gross Margin

38.1%

Operating Margin

35.0%

Net Margin

21.3%

ROE

7.3%

Total Assets

$14.2B

Source: XBRL data from CF Industries Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other CF Industries Quarterly Reports

Q2 2025 10-Q

Q1 2025 10-Q

Get deeper insights on CF Industries

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.